12:00 AM
 | 
Mar 29, 1999
 |  BC Week In Review  |  Company News  |  Deals

QLT PhotoTherapeutics Inc., Nippon Fine Chemical Co. Ltd., Parkedale Pharmaceuticals Inc., Raylo Chemicals Inc. deal

QLTI signed manufacturing agreements with the three companies for Visudyne verteporfin to treat ophthalmic conditions. Raylo will make the active ingredient, Nippon...

Read the full 96 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >